Trial Profile
Efficacy and Safety of Norditropin® (Somatropin) in Children With Prader-Willi Syndrome (PWS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2023
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 12 Apr 2014 New trial record